Cargando…
Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis
Atherosclerosis is an early pathological basis of numerous cardiovascular events that result in death or disability. Recent studies have described PCSK9 as a novel target for the treatment of atherosclerosis; PCSK9 is capable of degrading LDLR on the surface of hepatocytes through the regulation of...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992811/ https://www.ncbi.nlm.nih.gov/pubmed/36911736 http://dx.doi.org/10.3389/fimmu.2023.1126823 |